Document Detail


WAVE3 is associated with invasiveness in prostate cancer cells.
MedLine Citation:
PMID:  19395286     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Wiskott-Aldrich syndrome verprolin-homologous 3 (WAVE3) belongs to Wiskott-Aldrich syndrome family proteins (WASP), which, along with other members, play a critical role in the regulation of actin polymerization and cell motility. We investigated the expression pattern and the effects of manipulating endogenous WAVE3 expression in prostate cancer cells. MATERIALS AND METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR) of prostate cell lines and immunohistochemical staining of normal and cancer specimens for WAVE3 proteins were done. WAVE3 knockdown clones were synthesized using hammerhead ribozyme transgenes and transfected by electroporation into DU-145 and PC-3 cells. The impact of WAVE3 knockdown was studied using in vitro functional assays. RESULTS: RT-PCR for WAVE3 showed strong expression in both PC-3 and DU-145 cell lines. Immunohistochemistry of prostate tissue specimens showed that the cytoplasm of cancer cells had stronger staining than normal epithelium. The mean [(+/-standard error of mean (SEM)] invading cell number for PC-3(DeltaW3R1) and PC-3(DeltaW3R2) was 5.06 (+/-0.42) and 6.33 (+/-0.19), respectively, compared with PC-3(WT) (12.27 +/- 0.42; P < 0.001). Similarly, the mean (+/-SEM) invading cell numbers for DU-145(DeltaW3R1) and DU-145(DeltaW3R2) were 10.80 (+/-1.33) and 10.20 (+/-0.86) compared with DU-145(WT) (14.80 +/- 0.24, P < 0.05). No significant differences were observed in the adhesiveness and proliferation between the knockdown mutants and the wild types. CONCLUSIONS: This is the first report on the expression patterns and the functions of WAVE3 in prostate cancer cell lines. This study shows that WAVE3 is pivotal in controlling the invasiveness of prostate cancer cells. Further work is needed to assess WAVE3 as a potential marker for predicting tumor aggressiveness.
Authors:
Herman S Fernando; Andrew J Sanders; Howard G Kynaston; Wen G Jiang
Related Documents :
15548706 - Evidence that trpm8 is an androgen-dependent ca2+ channel required for the survival of ...
21569786 - Automated detection of hepatotoxic compounds in human hepatocytes using heparg cells an...
20212456 - Development of a continuous assay for the measurement of tissue factor procoagulant act...
1285216 - Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues.
10964666 - Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
6092046 - Synthesis of lung surfactant-associated glycoproteins by a549 cells: description of an ...
Publication Detail:
Type:  Journal Article     Date:  2009-04-22
Journal Detail:
Title:  Urologic oncology     Volume:  28     ISSN:  1873-2496     ISO Abbreviation:  Urol. Oncol.     Publication Date:    2010 May-Jun
Date Detail:
Created Date:  2010-05-04     Completed Date:  2010-07-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805460     Medline TA:  Urol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  320-7     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom. herman.fernando@yahoo.co.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blotting, Western
Cell Adhesion / genetics
Cell Line, Tumor
Cell Proliferation
Gene Expression
Gene Knockdown Techniques
Humans
Immunohistochemistry
Male
Neoplasm Invasiveness / genetics*
Prostatic Neoplasms / genetics*,  pathology*
Reverse Transcriptase Polymerase Chain Reaction
Transfection
Wiskott-Aldrich Syndrome Protein Family / biosynthesis*,  genetics
Chemical
Reg. No./Substance:
0/WASF3 protein, human; 0/Wiskott-Aldrich Syndrome Protein Family

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcino...
Next Document:  Impact of surgeon and hospital volume on outcomes of radical prostatectomy.